CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-10 | Ho Carole Chief Medical Officer | Sale | −711 | $18.62 | $13K | 0 |
| 2019-06-10 | Ho Carole Chief Medical Officer | Option exercise | +3,906 | $5.28 | $21K | 3,906 |
| 2019-06-10 | Ho Carole Chief Medical Officer | Sale | −3,906 | $18.81 | $73K | 0 |
| 2019-06-10 | Ho Carole Chief Medical Officer | Sale | −12,883 | $18.78 | $242K | 90,923 |
| 2019-06-10 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −711 | 95,169 | ||
| 2019-06-10 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −3,906 | 82,033 | ||
| 2019-06-03 | Watts Ryan J. President and CEO | Sale | −18,333 | $19.07 | $350K | 2,560,971 |
| 2019-05-30 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | SATO VICKI L Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | Klein Peter S Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | FLATLEY JAY T Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-30 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2019-05-14 | Watts Ryan J. President and CEO | Gift | −40,000 | 2,520,971 | ||
| 2019-05-13 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $21.09 | $53K | 640,089 |
| 2019-05-10 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $22.19 | $55K | 642,589 |
| 2019-05-10 | Ho Carole Chief Medical Officer | Option exercise | +2,546 | $5.28 | $13K | 2,546 |
| 2019-05-10 | Ho Carole Chief Medical Officer | Sale | −2,546 | $22.17 | $56K | 0 |
Page 38 of 53 · 1,053 trades